Abstract
US law requires the Food and Drug Administration (FDA) to disclose information on harmful and potentially harmful chemicals in cigarette smoke (i.e., constituents) to the public. To inform this effort, we sought to identify principles for creating constituent messages that effectively discourage smoking. Participants were an online convenience sample of 1,148 US smokers ages 18+. We developed a library of 76 messages about constituents only and constituents plus contextualizing information (i.e., toxic products that also contain the chemical, health effects, or both). We randomized smokers to receive 1 message from each of 7 message panels in a mixed between-/within-subjects experiment. Participants rated each message on perceived message effectiveness. Results indicated that smokers perceived messages about arsenic, formaldehyde, lead, uranium, and ammonia as more effective than messages about nitrosamines. Messages that contained information on toxic products, health effects, or both received higher effectiveness ratings than constituent-only messages. Among constituent-only messages, those that referenced multiple constituents received higher effectiveness ratings than those with fewer constituents. We conclude that constituent messages may have more impact if they pair known constituents with toxic product or health effect information. These message principles can be used to inform studies examining the impact of chemical messages on smoking beliefs and behavior.
Keywords: tobacco, constituent, chemical, disclosure, experiment, messaging, smoking
Tobacco use is responsible for nearly six million deaths each year,1 making it the leading cause of preventable death in the world. Approximately 20% of all deaths in the US are directly attributable to tobacco use.2 These deaths are the consequence of the myriad negative health effects of smoking such as cardiovascular disease, cancer, respiratory disease, and reproductive complications. Smoking also exacerbates communicable diseases, including tuberculosis and respiratory tract infections.3,4 The direct (i.e., healthcare expenses) and indirect (i.e., productivity losses) costs of smoking are substantial, with estimates as high as $193 billion per year in the US.5
Cigarette smoke contains more than 7,000 constituents, many of which are toxic to human health and at least 69 of which are carcinogenic.6–8 Some constituents occur naturally in tobacco (e.g., nicotine), some are added during the manufacturing process (e.g., ammonia), and most are generated through burning the tobacco and paper (e.g., acrolein).9–11 Carcinogenic constituents present in cigarettes include benzene, 1,3-butadiene, and formaldehyde, as well as tobacco-specific nitrosamines (nicotine-derived nitrosamine ketone or NNK, and N-Nitrosonornicotine or NNN).9,10,12,13 Different constituents have been linked to specific negative health consequences. For example, acrolein and acetaldehyde are two of the most harmful constituents to respiratory health, and arsenic and hydrogen cyanide pose great risk to cardiovascular health.12 In addition to direct health effects, some constituents (e.g., nicotine, ammonia) may cause indirect harm to consumers by increasing cigarette addictiveness, leading to higher intensity or frequency of tobacco use as well as hindering tobacco cessation success.14
The 2009 Family Smoking Prevention and Tobacco Control Act granted the US Food and Drug Administration (FDA) broad authority to regulate tobacco products, including educating the public about the harms of tobacco constituents.15 To that end, in 2012, FDA published draft guidance on 93 harmful and potentially harmful constituents in tobacco products and tobacco smoke16 and later released an abbreviated list of 18 cigarette smoke constituents prioritized for industry reporting. Cigarette manufacturers are required to submit information on the quantities of those 18 constituents to the FDA by cigarette brand and sub-brand.8,15 The FDA is required to eventually release this information to the public in a way that is both “understandable” and “not misleading.”14 In addition to enforcing industry reporting of constituents, FDA has the authority to communicate with the public about tobacco constituents in various ways (e.g., requiring constituent disclosure labels on packs) if the information benefits public health.15
Several studies have examined knowledge, risk perceptions, and attitudes about tobacco constituents, both qualitatively17–19 and quantitatively.17,20–22 These studies have indicated that the public has little knowledge about tobacco constituents beyond nicotine and tar, and that the public generally assumes that most harmful chemicals are added during the manufacturing process. As a consequence, many people erroneously perceive cigarettes without additives to be less harmful than those with additives.23 Studies have found that people want more readily accessible information about constituents and that well-designed constituent information increases knowledge and has potential to change behavior.18,24
Research has demonstrated that consumers are likely to better understand non-numerical, descriptive information about tobacco constituents compared to numerical information about constituent levels.17,25 Some evidence suggests that providing numerical information about quantities or amounts of constituents may mislead consumers by creating the impression that cigarettes with lower quantities of constituents cause less harm than those with higher quantities.25 This pattern of findings holds some parallels to the now disallowed marketing of some cigarette types as “light,” which consumers interpreted as presenting a lower health risk (due to low tar) compared to other cigarettes.26 To date, few studies have experimentally tested descriptive, non-numerical cigarette pack constituent disclosures to understand which descriptive disclosure messages have the greatest potential for increasing knowledge of constituent content and their associated harms. One set of “proof of concept” experiments found that adding health effect or toxic product information to a cigarette smoke constituent disclosure discouraged smoking more than disclosing just the constituent.27 Although informative, this experiment examined a limited range of constituents, toxic products, and health effects.
In order to develop evidence-based constituent disclosures appropriate for national dissemination via cigarette packs and other media, systematic research is needed to develop scientifically-supported messages and to identify principles of effective constituent disclosures. The current study builds upon a series of studies by our research team that began with a systematic review24 and focus groups examining smokers’ and non-smokers’ thoughts about cigarette smoke constituents.19 Then, we conducted nationally representative surveys assessing the public’s awareness and perceptions of constituents.28 Finally, we conducted a study to examine effective elements to use in disclosure messages.29 In the current message-testing study, we sought to examine: 1) whether perceived message effectiveness varied by constituent; 2) whether the presence of more than one constituent in a disclosure increased perceived message effectiveness; and 3) whether the presence of contextualizing information in disclosures – toxic products that also contain tobacco constituents and constituent-associated health effects – increased perceived message effectiveness.
Methods
Participants and Procedures
In April 2015, we recruited 1,148 US cigarette smokers ages 18 or older to participate in an online experiment of messages about chemicals in cigarette smoke. Recruitment took place through Amazon Mechanical Turk (MTurk), a web-based platform commonly used for social science and experimental research.30–33 Although MTurk uses nonprobability-based methods, MTurk samples are typically more representative of the US population than other convenience samples commonly used for social science and health research.30,32 Moreover, MTurk research replicates findings from a variety of studies and settings.30,31,34 To recruit smokers from MTurk, we used 3 methods. First, we launched a 5-question screener with items about health behaviors, including smoking, and invited all participants (~300) who indicated they smoked cigarettes some days or every day to take part in our study. We also invited ~2,000 cigarette smokers from previous MTurk studies conducted by the team in the prior 18 months. These methods together yielded about 900 smokers. Finally, we opened up the survey to all MTurk workers, and used recruitment language indicating that we preferred cigarette smokers, but that non-smokers were welcome to participate as well. This method yielded ~250 additional smokers. The analytic dataset excluded any non-smokers who took the survey. After providing informed consent, participants completed an online questionnaire. Participants received $1.81 USD after completing the survey. The University of North Carolina at Chapel Hill Institutional Review Board approved this study.
Experimental Manipulations
Participants received one message randomly selected from each of seven message panels for a total of seven messages in this mixed within/between experimental study. We presented the messages in a random order. Six of the panels each featured one constituent previously demonstrated to discourage smoking (arsenic, formaldehyde, uranium, lead, and ammonia)28,35 or an especially toxic carcinogen (nitrosamines).36 Five of the panels included 11 message structure variations about each constituent (Table 1): constituent only (one message), constituent plus one toxic product that the constituent is also found in (two messages), constituent plus two toxic products (one message), constituent plus one health effect (two messages), constituent plus two health effects (one message), and constituent plus one toxic product and one health effect (four messages). Choice of toxic products and health effects was informed by the scientific literature,37–41 consultations with toxicologists, and an earlier study that identified toxic products and health effects that especially discourage smoking.29 The sixth panel (nitrosamines) was the same but had only 10 message variations because the sole toxic product associated with nitrosamines was tobacco. Finally, the seventh panel consisted of 11 messages: nine constituent-only messages featuring two, three, and four constituents (e.g., Cigarette smoke contains arsenic, formaldehyde, lead, and nitrosamines), as well as two additional messages (Ammonia is added to cigarettes, which makes them more addictive; Cigarette smoke has over 70 chemicals that cause cancer and death). Altogether, we developed and tested 76 unique messages (see online Appendix for message library of 76 messages).
Table 1.
Message panel example of 11 message variations tested for formaldehyde
| Toxic Products | |||||
|---|---|---|---|---|---|
| None | 1 Product (Embalming fluid) |
1 Product (Car exhaust) |
2 Products (Embalming fluid and Car exhaust) |
||
| Health Effects | None | Cigarette smoke contains formaldehyde. | Cigarette smoke contains formaldehyde. This is found in embalming fluid. | Cigarette smoke contains formaldehyde. This is found in car exhaust. | Cigarette smoke contains formaldehyde. This is found in embalming fluid and car exhaust. |
|
1 Health Effect (Chronic bronchitis) |
Cigarette smoke contains formaldehyde. This causes chronic bronchitis. | Cigarette smoke contains formaldehyde. This is found in embalming fluid and causes chronic bronchitis. | Cigarette smoke contains formaldehyde. This is found in car exhaust and causes chronic bronchitis. | – | |
|
1 Health Effect (Throat cancer) |
Cigarette smoke contains formaldehyde. This causes throat cancer. | Cigarette smoke contains formaldehyde. This is found in embalming fluid and causes throat cancer. | Cigarette smoke contains formaldehyde. This is found in car exhaust and causes throat cancer. | – | |
|
2 Health Effects (Chronic bronchitis and Throat cancer) |
Cigarette smoke contains formaldehyde. This causes chronic bronchitis and throat cancer. | – | – | – | |
Note. Underlining added to Table to show similarities and differences in messages. Participants saw messages without underlining.
Measures
Participants rated each of the seven constituent messages on perceived message effectiveness, believability, and reactance. The random selection of a message from each panel resulted in an unequal number of ratings by message—the average number of ratings for a message was 106 (SD = 11). After participants rated their assigned messages, we assessed demographics and tobacco use.
Perceived message effectiveness
The survey assessed our primary outcome of perceived message effectiveness using three items: “This message makes smoking seem less appealing to me;” “How much does this message make you concerned about the health effects of smoking?” and “How much does this message discourage you from wanting to smoke?” The 5-point response scales ranged from “strongly disagree” (coded as 1) to “strongly agree” (5) for the first item and “not at all” (1) to “very much” (5) for the other two. We created a perceived message effectiveness composite score by averaging these three items together (Cronbach’s alpha = .93).
Believability and reactance
The survey assessed message believability using two items, “How believable is this message?” and “I already knew about the information in this message.” The 5-point response scale ranged from “not at all” to “extremely.” To disentangle the person- level and message-level effects of believability on perceived message effectiveness we used a centering approach42 to create two variables for each construct. First, for each message rating we averaged the two believability scores to create a composite measure (r = .51). We next computed each person’s average believability score across their seven constituent messages (i.e., person-level believability). Finally, we subtracted each person’s average believability score from their believability score for each of their seven messages, resulting in a variable indicating whether a person’s believability score for a particular message was higher or lower than their average believability score (i.e., message-level believability). This created both a person-level and message-level variable for planned multilevel analyses. The survey assessed message reactance using two items:43 “This message is trying to manipulate me;” and “This message irritates me.” The 5-point response scale ranged from “strongly disagree” (coded as 1) to “strongly agree” (5). We averaged two items to create a reactance score (r = .39) and followed the same variable centering procedure as for believability.
Demographics and tobacco use
The survey assessed sex (female [coded as 0], male [1]), sexual orientation (straight or heterosexual [0], gay, lesbian, or bisexual [1]), age, education (greater than high school diploma or GED [0], high school education or less [1]), numeracy using four validated mathematical word problems44,45 (3–4 numeracy items correct [0], < 3 numeracy items correct [1]), health literacy using four items from the S-TOFHLA,46 income, race (non-white [0], white [1]), ethnicity, smoking frequency (does not smoke every day [0], smokes every day [1]), and other tobacco product use.
Data Analysis
To identify message-level and person-level predictors of perceived message effectiveness, we built a multilevel model (MLM). As perceived message effectiveness was normally distributed, we conducted the analyses using the PROC MIXED procedure in SAS 9.3 using maximum likelihood estimation and a Satterthwaite approximation for degrees of freedom. The analysis strategy employed a bottom-up model building approach. We first examined an intercept-only model and computed the intraclass correlation (ICC) to quantify message characteristic variability (Level 1). Next, we individually examined each message characteristic (Level 1) and person-characteristic (Level 2) as predictors in univariate models, treating the intercept as a random effect. Finally, we examined an adjusted model that included any variables with p-values < 0.10 in the unadjusted models as predictors. The ICC for the perceived effectiveness multilevel model was 0.67, indicating that two-thirds of the variability for the outcome variable was at the person level and the remaining one-third was at the message level. We report findings from the models as unstandardized regression coefficients (b). Critical alpha was 0.05 and statistical tests were two-tailed.
Results
Smokers’ average age was 35.7 (SD = 11.2; range 18–73 years). The majority were white (85%), had at least some college education (83%) and made less than $50,000 per year (60%). Participants reported smoking an average of 14.6 cigarettes per day (SD = 8.5). Fifty-six percent of smokers reported having used a tobacco product other than cigarettes at least once within the last 30 days (Table 2).
Table 2.
Participant Characteristics, n = 1,148 smokers (April 2015)
| % (n) or M ± SD | |
|---|---|
| Male | 52.1% (598) |
| Gay, lesbian or bisexual | 11.9% (137) |
| Age, years | 35.7 ± 11.2 |
| Age category, years | |
| 18–25 | 18.1% (208) |
| 26–34 | 37.4% (429) |
| 35–44 | 23.1% (265) |
| 45–54 | 12.9% (148) |
| 55–64 | 6.9% (79) |
| 65+ | 1.3% (15) |
| Education | |
| High school diploma or less | 17.4% (200) |
| Some college | 33.6% (386) |
| Associate’s degree | 12.6% (145) |
| Bachelor’s degree | 30.1% (346) |
| Master’s degree | 4.6% (53) |
| Professional or doctoral degree | 1.5% (17) |
| Low numeracy, < 4 items correct | 29.8% (342) |
| Low health literacy, < perfect score | 31.8% (365) |
| Income | |
| < $25,000 per year | 24.0% (275) |
| $25,000 – $49,999 per year | 36.1% (414) |
| $50,000 – $74,999 per year | 22.6% (259) |
| $75,000 – $100,000 per year | 9.4% (108) |
| > $100,000 per year | 7.9% (91) |
| Race | |
| White | 84.8% (973) |
| Black or African American | 6.4% (73) |
| Asian | 5.0% (57) |
| Native American | 0.9% (10) |
| Native Hawaiian/Pacific Islander | 0.3% (4) |
| Other | 2.7% (31) |
| Hispanic | 6.4% (73) |
| Cigarettes smoked per day | 14.6 ± 8.5 |
| Other tobacco product use in past 30 days | |
| E-cigarettes or other vaping devices | 43.0% (494) |
| Traditional cigars | 10.9% (125) |
| Cigarillos, filtered cigars, or little cigars | 12.5% (143) |
| Pipe filled with tobacco | 3.4% (39) |
| Hookah | 7.1% (82) |
| Smokeless tobacco | 6.4% (73) |
| None of the above | 43.6% (501) |
Type and Number of Constituents
Perceived effectiveness ranged from a low of M=2.86 for messages with nitrosamines to a high of M=3.34 for messages with arsenic (Table 3 and Figure 1). Compared to messages with nitrosamines, smokers perceived messages with the other five constituents as more effective: arsenic (b =0.37, p <0 .001), formaldehyde (b =0.26, p <0 .001), lead (b =0.23, p <0.001), uranium (b =0.37, p <0.001), and ammonia (b =0.12, p <0.001) in the adjusted multilevel analysis (Table 4).
Table 3.
Mean (SD) Perceived Effectiveness of Messages, by Constituent, n = 1,148 smokers (April 2015)
| Condition | Arsenic i=1,692 |
Formaldehyde i=1,666 |
Lead i=1,453 |
Uranium i=1,677 |
Ammonia i=1,540 |
Nitrosamines i=1,582 |
|
|---|---|---|---|---|---|---|---|
| 1 | Constituent(s) Only, i=1,593 | 3.17 (1.05) | 2.96 (1.18) | 3.00 (1.10) | 2.68 (1.21) | 3.02 (1.18) | 2.27 (1.00) |
| 2 | One Toxic Product, i=1,284 | 3.30 (1.16) | 3.08 (1.07) | 2.95 (1.21) | 3.14 (1.21) | 2.95 (1.15) | 2.06 (1.03) |
| 3 | Two Toxic Products, i=484 | 3.25 (1.23) | 3.34 (1.05) | 3.25 (1.21) | 3.18 (1.33) | 2.98 (1.19) | . |
| 4 | One Health Effect, i=1,228 | 3.34 (1.02) | 3.32 (1.08) | 3.16 (1.18) | 3.17 (1.22) | 3.04 (1.10) | 3.33 (1.10) |
| 5 | Two Health Effects, i=650 | 3.27 (1.03) | 3.37 (1.16) | 3.39 (1.10) | 3.42 (1.24) | 3.22 (1.10) | 3.28 (1.18) |
| 6 | One Product & Health Effect, i=2,588 | 3.43 (1.13) | 3.33 (1.13) | 3.15 (1.15) | 3.10 (1.23) | 3.19 (1.09) | 3.14 (1.14) |
|
| |||||||
| OVERALL | 3.34 (1.11) | 3.26 (1.11) | 3.13 (1.17) | 3.12 (1.24) | 3.09 (1.12) | 2.86 (1.21) | |
i = number of message ratings for that message type
Figure 1.

Perceived message effectiveness by constituent type (Panel A) and number of constituents (Panel B). Error bars show standard errors.
Table 4.
Multilevel Model Predicting Perceived Message Effectiveness, n = 1,148 smokers (April 2015)
| Unadjusted Model |
Adjusted Model |
|||
|---|---|---|---|---|
| b | SE | b | SE | |
| Intercept | 3.13** | 0.03 | 3.02** | 0.18 |
| Message characteristics (Level 1) | ||||
| Constituent | ||||
| Arsenic | 0.47** | 0.03 | 0.37** | 0.03 |
| Formaldehyde | 0.39** | 0.03 | 0.26** | 0.03 |
| Lead | 0.27** | 0.03 | 0.23** | 0.03 |
| Uranium | 0.25** | 0.03 | 0.37** | 0.03 |
| Ammonia | 0.23** | 0.03 | 0.12** | 0.03 |
| Nitrosamines (ref) | . | . | . | . |
| Constituent message content | ||||
| One constituent (ref) | . | . | . | . |
| Two constituents | 0.22** | 0.05 | . | . |
| Three constituents | 0.37** | 0.05 | . | . |
| Four constituents | 0.41** | 0.05 | . | . |
| 70 chemicals | 0.66** | 0.07 | . | . |
| Ammonia added to make cigarettes more addictive | 0.09 | 0.07 | . | . |
| One constituent with one toxic product | 0.12** | 0.03 | 0.13** | 0.03 |
| One constituent with two toxic products | 0.44** | 0.04 | 0.35** | 0.04 |
| One constituent with one health effect | 0.46** | 0.03 | 0.42** | 0.03 |
| One constituent with two health effects | 0.57** | 0.04 | 0.50** | 0.04 |
| One constituent with one product & one health effect | 0.47** | 0.03 | 0.45** | 0.03 |
| Reactance, deviation from person’s M score | −0.21** | 0.01 | −0.14** | 0.02 |
| Believability, deviation from person’s M score | 0.23** | 0.009 | 0.19** | 0.01 |
| Person characteristics (Level 2) | ||||
| Male | −0.12* | 0.06 | 0.00 | 0.05 |
| Gay, lesbian or bisexual | −0.31** | 0.09 | −0.27** | 0.08 |
| Age in decades, grand mean centered | −0.03 | 0.03 | . | . |
| White (vs. all other racial groups) | −0.10 | 0.08 | . | . |
| Low education, high school or less | 0.14† | 0.08 | 0.03 | 0.07 |
| Low numeracy | 0.36** | 0.06 | 0.24** | 0.06 |
| Smoked every day (vs. some days) | −0.24** | 0.06 | −0.26** | 0.03 |
| Reactance, person’s M score | −0.41** | 0.03 | −0.23** | 0.03 |
| Believability, person’s M score | 0.37** | 0.04 | 0.09* | 0.04 |
Note. Outcome was 3-item perceived message effectiveness scale (range 1–5). Intraclass correlation (ICC) = 0.67. b = unstandardized regression coefficient. SE = standard error of the estimate. M=mean. SD = standard deviation. The 1, 2, 3, and 4 constituent messages and the 70 carcinogenic chemicals messages could not be included in the adjusted model because each participant was randomized to receive only 1 of those messages. Therefore, for the adjusted model, the reference group for constituent message content was all constituent-only messages that a participant received.
p≤.08;
p<.05,
p<.001
Perceived effectiveness of the constituent-only messages varied by number of constituents, with a gradual increase in perceived effectiveness ratings for messages with one (M=2.83), two (M=2.99), three (M=3.11), four (M=3.19), and 70 (non-specified) carcinogenic constituents (M=3.93) (Figure 1). Messages with two (b =0.22, p<0.001), three (b =0.37, p<0.001), or four (b =0.41, p<0.001) constituents elicited higher perceived effectiveness than messages containing one constituent, in adjusted analyses (Table 4 and Figure 1).
Contextualizing Information
Perceived effectiveness was higher for messages with constituents plus contextualizing information (M=3.50) compared to messages without contextualizing information (M=2.85; p <0.001). Messages containing either type of information – toxic products or health effects – received higher perceived effectiveness ratings than the constituent-only messages in the adjusted multilevel analysis (p <0.001), as did messages with two toxic products or health effects (p <0.001) or messages containing both a single toxic product and a single health effect (p <0.001) (Table 4).
Covariates
Messages rated as more believable had higher perceived effectiveness ratings (b =0.19, p <0.05), while messages eliciting greater reactance had lower perceived effectiveness ratings (b =−0.14, p <0.001). Several person-level variables were associated with perceived message effectiveness. Being gay, lesbian or bisexual (b = −0.27, p <0.001); smoking every day (b =−0.26, p <0.001); and generally experiencing more reactance to the constituent messages (b =−0.23, p< 0.001) were all associated with lower perceived effectiveness. People with low numeracy (b =0.24, p <0.001) and those who generally found constituent messages more believable (b =0.09, p <0.05) reported higher perceived message effectiveness.
Discussion
Our study identified several principles that explain why some constituent messages may outperform others (Table 5), and these findings corroborate and extend our previous work. 27, 28,35 The first principle is that messages with constituents that are familiar and have negative associations elicit higher perceived effectiveness. In a nationally representative survey, only 11% of adult smokers were aware that nitrosamines are in cigarette smoke, compared to 50% for arsenic, 49% for formaldehyde, and 39% for ammonia, and higher awareness was associated with greater discouragement from wanting to smoke.28 In qualitative work, participants have reported that familiar constituents with which they have negative associations are most likely to discourage them from smoking.19 The present findings are consistent with this work, with nitrosamine messages being perceived as least effective as compared to the five better-known constituents tested. From a public health perspective, nitrosamines are one of the most dangerous carcinogens in cigarette smoke.36 However, without the benefit of prior knowledge or negative associations, brief messages about unfamiliar constituents may have little impact. While messages about familiar constituents are likely to have more impact in the short term, in the longer term campaigns could be used to educate the public about lesser known constituents such as nitrosamines, thereby gradually increasing the impact of messages about those constituents.28
Table 5.
Principles for Communicating about Harmful Constituents
| Principle | Example Message | Evidence |
|---|---|---|
| Communicate about familiar constituents that have negative associations, such as arsenic, formaldehyde, and lead | Cigarette smoke contains arsenic. | Hall et al.34 Moracco et al.19 Brewer et al.28 Current study |
| Pair constituents with a toxic product…. or health effect… or both. |
Cigarette smoke contains arsenic. This is found in termite poison. Cigarette smoke contains arsenic. This causes heart damage. Cigarette smoke contains arsenic. This is found in termite poison and causes heart damage. |
Baig et al.45 Current study |
| If messages can use only the constituent name, use multiple constituents | Cigarette smoke contains arsenic, formaldehyde, uranium, and lead. | Current study |
The second principle is that messages that pair constituents with information about associated toxic products, health effects, or both leads to higher ratings of effectiveness than messages about constituents alone. This finding – that pairing constituents with contextualizing information facilitates perceived message effectiveness – is consistent with a recent experiment that reported similar results in nationally representative surveys of adolescents and adults.27 Such contextualizing information likely helps people better understand the potential harms of cigarette constituents.19 In the case of a toxic product (e.g., Cigarette smoke contains arsenic. This is found in termite poison.), this information may help the public better understand the toxicity of a particular constituent. In the case of health effects (e.g., Cigarette smoke contains arsenic. This causes heart damage), this information explains to smokers how a particular harmful constituent affects the body. In qualitative work, participants have reported wanting to know more about the many constituents in cigarette smoke, including constituents’ impact on the body.19 Also, while toxic product and health effect information presented in a single message effectively communicates smoking harms, our study – as well as previous work27– suggests that messages referring to either a toxic product or a health effect are similarly effective. Our findings indicate there does not appear to be a large additional benefit of including both types of contextualizing information in a constituent message,27 especially on a cigarette pack where space is typically quite limited. Also, if new constituent disclosures were to replace old messages and rotate on a regular basis,47 smokers would ultimately be exposed to a variety of different constituent messages even if each message only disclosed a single toxic product or health effect. Many countries have used such a rotation approach to great effect with cigarette pack warnings.47–49
A final principle is that, in cases where communications can only be about constituents themselves (due to length, legal, or other issues), communicating about a single constituent may be somewhat less effective (e.g., Cigarette smoke contains arsenic) as compared to messages with multiple constituents. This finding is especially important given that the only constituent-based message that, to date, has ever been used on packs in the US, (“Cigarette smoke contains carbon monoxide”), references a single constituent. Our results suggest that if a constituent message can only list constituent names with no contextualizing information, then increasing the number of listed constituents may lead to greater message impact. However, if possible, single constituents should be paired with toxic products or health effects because constituent only messages provide smokers with little information regarding the meaning of constituents,19 and may have less impact.27
Limitations and Future Directions
One study limitation is our use of a convenience sample, although the findings are consistent with a recent nationally representative survey study,27 suggesting that these message principles are likely to be robust. Second, our evaluation of multiple constituent-only messages was limited to one message panel with minimal variations, and we did not test some variations of messages because we thought they would be difficult to understand and impractical to implement on cigarette packs (e.g., multiple constituents with toxic products and health effects). Finally, our primary outcome was perceived (not actual) message effectiveness. While evidence suggests that messages with higher perceived effectiveness ratings have greater impact on smoking-related behaviors,50,51 such measures do not directly assess actual message impact (i.e., change in beliefs, behaviors).
Future work is needed to establish the impact of cigarette pack constituent disclosures on smoking knowledge, beliefs and behavior, and the message principles identified here can contribute to such work, as can our library of constituent messages (see online appendix). Follow-up experimental studies are needed to examine the impact of adding evidence-based constituent disclosures to cigarette packs on cessation-related outcomes. The ultimate value in disclosures relies on evidence that they have an actual (and not just perceived) impact on smoking knowledge, beliefs, intentions, and perhaps behavior. Additional research should also consider other aspects of the messages beyond message content, such as the impact of size, font, color, and placement.
Conclusion
Since 2009, the FDA has had broad authority to regulate tobacco products, including educating the public about the harms of tobacco constituents. Evidence-based constituent messages – on cigarette packs and potentially in public education campaigns – could be an effective way to communicate this information to the public and have an impact. Our findings suggest that to be most effective, constituent messages should follow the principles identified in this study. That is, they should prioritize familiar constituents and pair those constituents with information about an associated toxic product or health effect. Effective communication with the public regarding harmful constituents shows great promise for discouraging smoking and encouraging quitting behavior, thus improving public health.
Supplementary Material
Acknowledgments
Research reported in this publication was supported by P50CA180907 from the National Cancer Institute and the FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.
Contributor Information
Seth M. Noar, School of Media and Journalism, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
Dannielle E. Kelley, School of Media and Journalism, University of North Carolina at Chapel Hill
Marcella H. Boynton, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
Jennifer C. Morgan, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
Marissa G. Hall, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
Jennifer R. Mendel, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Kurt M. Ribisl, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
Noel T. Brewer, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
References
- 1.World Health Organization. WHO report on the global tobacco epidemic, 2013: Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva, Switzerland: World Health Organization; 2013. [Google Scholar]
- 2.Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–1245. doi: 10.1001/jama.291.10.1238. [DOI] [PubMed] [Google Scholar]
- 3.World Health Organization. WHO global report: Mortality attributable to tobacco. Geneva, Switzerland: 2012. [Google Scholar]
- 4.U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. Printed with corrections, January 2014. [Google Scholar]
- 5.US National Cancer Institute and World Health Organization. The Economics of Tobacco and Tobacco Control. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2016. (National Cancer Institute Tobacco Control Monograph 21. NIH Publication No. 16-CA-8029A). Geneva, CH: World Health Organization. [Google Scholar]
- 6.Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press; 2008. [Google Scholar]
- 7.Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Pub Health. 2011;8(2):613–628. doi: 10.3390/ijerph8020613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.U.S. Food and Drug Administration. Reporting harmful and potentially harmful constituents in tobacco products and tobacco smoke under section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products; Rockville, MD: 2012. [Google Scholar]
- 9.Hecht SS. Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob Res. 2012;14(1):18–28. doi: 10.1093/ntr/ntq216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. Lyon, France: 2004. [Google Scholar]
- 11.U.S. Department of Health and Human Services. 2014 Poverty Guidelines. 2014 http://aspe.hhs.gov/poverty/14poverty.cfm. Accessed March 17, 2014.
- 12.Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003;12(4):424–430. doi: 10.1136/tc.12.4.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Biener L, Nyman AL, Stepanov I, Hatsukami D. Public education about the relative harm of tobacco products: an intervention for tobacco control professionals. Tob Control. 2013;23:385–388. doi: 10.1136/tobaccocontrol-2012-050814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.U.S. Food and Drug Administration. Guidance for industry and FDA staff: “Harmful and potentially harmful constituents” in tobacco products as used in section 904(e) of the Federal Food, Drug, and Cosmetic Act. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products; 2011. [Google Scholar]
- 15.Public Law 111-31, H.R. 1256. http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf.
- 16.U.S. Food and Drug Administration. Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Fed Regist. 2012;77(64):20034–20037. [Google Scholar]
- 17.Environics Research Group. Toxics Information on Cigarette Packaging: Results of a Survey of Smokers. Toronto, Canada: Health Canada; 2003. [Google Scholar]
- 18.Swayampakala K, Thrasher JF, Hammond D, et al. Pictorial health warning label content and smokers’ understanding of smoking-related risks—a cross-country comparison. Health Educ Res. 2014;30(1):35–45. doi: 10.1093/her/cyu022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Moracco KE, Morgan JC, Mendel J, et al. “My First Thought was Croutons”: Perceptions of cigarettes and cigarette smoke constituents among adult smokers and nonsmokers. Nicotine Tob Res. 2016;18(7):1566–1574. doi: 10.1093/ntr/ntv281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Brewer NT, Hall MG, Lee JGL, Noar SM, Ribisl KM. Testing warning messages on smokers’ cigarette packages: A standardized protocol. Tob Control. 2016;25(2):153–159. doi: 10.1136/tobaccocontrol-2014-051661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cummings KM, Hyland A, Giovino GA, Hastrup JL, Bauer JE, Bansal MA. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res. 2004;6(Suppl 3):S333–340. doi: 10.1080/14622200412331320734. [DOI] [PubMed] [Google Scholar]
- 22.Hammond D, Fong GT, McNeill A, Borland R, Cummings KM. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: Findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15(Suppl 3):iii19–25. doi: 10.1136/tc.2005.012294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pearson JL, Richardson A, Feirman SP, et al. American Spirit pack descriptors and perceptions of harm: A crowdsourced comparison of modified packs. Nicotine Tob Res. 2016;18(8):1749–1756. doi: 10.1093/ntr/ntw097. [DOI] [PubMed] [Google Scholar]
- 24.Morgan JC, Byron MJ, Baig SA, Stepanov I, Brewer NT. How people think about the chemicals in cigarette smoke: a systematic review. J Behav Med. 2017 doi: 10.1007/s10865-017-9823-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hammond D, White CM. Improper disclosure: tobacco packaging and emission labelling regulations. Pub Health. 2012;126(7):613–619. doi: 10.1016/j.puhe.2012.03.012. [DOI] [PubMed] [Google Scholar]
- 26.Gilpin EA, Emery S, White MM, Pierce JP. Does tobacco industry marketing of ‘light’ cigarettes give smokers a rationale for postponing quitting? Nicotine Tob Res. 2002;4(Suppl 2):S147–155. doi: 10.1080/1462220021000032870. [DOI] [PubMed] [Google Scholar]
- 27.Baig SA, Byron MJ, Boynton MH, Brewer NT, Ribisl KM. Communicating about cigarette smoke constituents: An experimental comparison of two messaging strategies. J Behav Med. 2016;40:352. doi: 10.1007/s10865-016-9795-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Brewer NT, Morgan JC, Baig SA, Mendel JR, Boynton MH, Pepper JK, Byron MJ, Noar SM, Agans RP, Ribisl KM. Public understanding of cigarette smoke constituents: Three United States surveys. Tob Control. 2017 doi: 10.1136/tobaccocontrol-2015-052897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kelley DE, Boynton MH, Noar SM, et al. Effective message elements for disclosures about chemicals in cigarette smoke. Nicotine Tob Res. 2017 doi: 10.1093/ntr/ntx109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Berinsky AJ, Huber GA, Lenz GS. Evaluating online labor markets for experimental research: Amazon.com’s Mechanical Turk. Polit Anal. 2012;20(3):351–368. [Google Scholar]
- 31.Buhrmester M, Kwang T, Gosling SD. Amazon’s Mechanical Turk: A new source of inexpensive, yet high-quality, data? Perspect Psychol Sci. 2011;6(1):3–5. doi: 10.1177/1745691610393980. [DOI] [PubMed] [Google Scholar]
- 32.Paolacci G, Chandler J, Ipeirotis P. Running experiments on Amazon Mechanical Turk. Judgment and Decision Making. 2010;5(5):411–419. [Google Scholar]
- 33.Rand DG. The promise of Mechanical Turk: how online labor markets can help theorists run behavioral experiments. J Theor Biol. 2012;299:172–179. doi: 10.1016/j.jtbi.2011.03.004. [DOI] [PubMed] [Google Scholar]
- 34.Goodman JK, Cryder CE, Cheema A. Data collection in a flat world: The strengths and weaknesses of Mechanical Turk samples. J Behav Decis Making. 2012;26(3):213–224. [Google Scholar]
- 35.Hall MG, Ribisl KM, Brewer NT. Smokers’ and nonsmokers’ beliefs about harmful tobacco constituents: Implications for FDA communication efforts. Nicotine Tob Res. 2014;16(3):343–350. doi: 10.1093/ntr/ntt158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hecht SS, Stepanov I, Carmella SG. Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Accounts Chem Res. 2016;49(1):106–114. doi: 10.1021/acs.accounts.5b00472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Abadin H, Ashizawa A, Stevens Y, et al. Toxicological profile for lead. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services; 2007. [PubMed] [Google Scholar]
- 38.Roney N, Llados F, Little S, Knaebel D. Toxicological Profile of ammonia. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services; 2004. [Google Scholar]
- 39.Wilbur HS, Harris OM, McClur PR, Spoo W. Toxicological profile for formaldehyde. Atlanta, GA: Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services; 1999. [Google Scholar]
- 40.Chou S, Harper C, Ingerman L, et al. Toxicological profile for arsenic. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services; 2007. [Google Scholar]
- 41.Keith S, Faroon O, Roney N, et al. Toxicological profile for uranium. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services; 2013. [PubMed] [Google Scholar]
- 42.Curran PJ, Bauer DJ. The disaggregation of within-person and between-person effects in longitudinal models of change. Annu Rev Psychol. 2011;62:583–619. doi: 10.1146/annurev.psych.093008.100356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hall MG, Sheeran P, Noar SM, Ribisl KM, Bach LE, Brewer NT. Reactance to Health Warnings Scale: Development and Validation. Ann Behav Med. 2016;50(5):736–750. doi: 10.1007/s12160-016-9799-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997;127(11):966–972. doi: 10.7326/0003-4819-127-11-199712010-00003. [DOI] [PubMed] [Google Scholar]
- 45.Lipkus IM, Samsa G, Rimer BK. General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001;21(1):37–44. doi: 10.1177/0272989X0102100105. [DOI] [PubMed] [Google Scholar]
- 46.Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to measure functional health literacy. Patient Educ Couns. 1999;38(1):33–42. doi: 10.1016/s0738-3991(98)00116-5. [DOI] [PubMed] [Google Scholar]
- 47.Noar SM, Francis DB, Bridges C, Sontag JM, Ribisl KM, Brewer NT. The impact of strengthening cigarette pack warnings: Systematic review of longitudinal observational studies. Soc Sci Med. 2016;164:118–129. doi: 10.1016/j.socscimed.2016.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Noar SM, Francis DB, Bridges C, Sontag JM, Brewer NT, Ribisl KM. Effects of strengthening cigarette pack warnings on attention and message processing: A systematic review. Journalism Mass Commun. 2017;94(2):416–442. doi: 10.1177/1077699016674188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Hammond D. Health warning messages on tobacco products: a review. Tob Control. 2011;20(5):327–337. doi: 10.1136/tc.2010.037630. [DOI] [PubMed] [Google Scholar]
- 50.Brennan E, Durkin SJ, Wakefield MA, Kashima Y. Assessing the effectiveness of antismoking television advertisements: do audience ratings of perceived effectiveness predict changes in quitting intentions and smoking behaviours? Tob Control. 2014;23(5):412–418. doi: 10.1136/tobaccocontrol-2012-050949. [DOI] [PubMed] [Google Scholar]
- 51.Davis KC, Duke J, Shafer P, Patel D, Rodes R, Beistle D. Perceived effectiveness of antismoking ads and association with quit attempts among smokers: Evidence from the tips from former smokers campaign. Health Commun. 2017;32(8):931–938. doi: 10.1080/10410236.2016.1196413. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
